{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:15:38Z","timestamp":1767791738510,"version":"3.49.0"},"reference-count":19,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2024,11,6]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Secondary sclerosing cholangitis (SSC) represents a disease with a poor prognosis increasingly diagnosed in clinical settings. Notably, SSC in critically ill patients (SSC-CIP) is the most frequent cause. Variables associated with worse prognosis remain unclear. The primary aim of this study was to identify factors associated with transplant-free survival in SSC-CIP patients using readily available data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cohort of 47 patients diagnosed with SSC-CIP was retrospectively analysed for clinical, biochemical and endoscopic variables. Kaplan-Meier survival curves, log-rank tests and univariate Cox proportional hazards models were used to assess associations with transplant-free survival. A multivariable Cox regression model was constructed using Lasso regularisation and validated with Bootstrap resampling. Model performance was assessed using the C-statistic for discrimination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Kaplan-Meier analysis identified bile duct obstruction requiring stent placement, and cholangitis episodes, as significant prognostic factors. In univariable analysis, age over 47 years (HR 2.61 (95% CI 1.02, 7.06), p=0.04), at least one cholangitis episode (HR 2.46 (95% CI 1.005, 6.06), p=0.04), stent placement (HR 2.89 (95% CI 1.13, 7.38), p=0.03), lower albumin levels (HR 0.52 (95% CI 0.28, 0.97), p=0.04) and higher international normalised ratio (INR) (HR 3.22 (95% CI 1.09, 9.53), p=0.03) were significant. Multivariable analysis showed that age at diagnosis, albumin and INR were significant independent predictors. The C-index was 0.78 (95% CI 0.65, 0.91), surpassing the model of end-stage liver disease score\u2019s prognostic accuracy (Concordance Index at 3 years: 66.2% vs 74.9%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings provide valuable insights for establishing standard exception criteria for this rare liver disease, which could lead to improved organ allocation. Further prospective multicentre studies are necessary to validate our findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2024-001571","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T22:55:38Z","timestamp":1736031338000},"page":"e001571","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic factors for transplant-free survival in patients with secondary sclerosing cholangitis associated with critical illness"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1031-6418","authenticated-orcid":false,"given":"Georgios","family":"Konstantis","sequence":"first","affiliation":[{"name":"Universit\u00e4tsklinikum Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorsa Ghaffar Loy","family":"Moghadam","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nargiz","family":"Nuruzade","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gerges","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen Medizinische Fakult\u00e4t, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Willuweit","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisan","family":"Kahraman","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, Max Grundig Klinik GmbH, Buhl, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Passenberg","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jassin","family":"Rashidi-Alavijeh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Transplant Medicine, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"2026010701050453000_12.1.e001571.1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-017-0546-0"},{"key":"2026010701050453000_12.1.e001571.2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","author":"Chazouilleres","year":"2022","journal-title":"J Hepatol"},{"key":"2026010701050453000_12.1.e001571.3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1572-0241.2005.41526.x","article-title":"Secondary Sclerosing Cholangitis: A Comparison to Primary Sclerosing Cholangitis","volume":"100","author":"Gossard","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2026010701050453000_12.1.e001571.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01118.x"},{"key":"2026010701050453000_12.1.e001571.5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002188","article-title":"Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases","volume":"94","author":"Leonhardt","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2026010701050453000_12.1.e001571.6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2007-967024","article-title":"Poor outcome in progressive sclerosing cholangitis after septic shock","volume":"40","author":"Kulaksiz","year":"2008","journal-title":"Endoscopy"},{"key":"2026010701050453000_12.1.e001571.7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s12328-022-01687-5","article-title":"Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature","volume":"15","author":"Bauer","year":"2022","journal-title":"Clin J Gastroenterol"},{"key":"2026010701050453000_12.1.e001571.8","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/liv.14971","article-title":"Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19","volume":"41","author":"B\u00fctikofer","year":"2021","journal-title":"Liver Int"},{"key":"2026010701050453000_12.1.e001571.9","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1093\/cid\/ciac565","article-title":"Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study","volume":"76","author":"Hunyady","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026010701050453000_12.1.e001571.10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000528689","article-title":"Secondary Sclerosing Cholangitis due to Severe COVID-19: An Emerging Disease Entity?","volume":"104","author":"Seifert","year":"2023","journal-title":"Digestion"},{"key":"2026010701050453000_12.1.e001571.11","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s12072-023-10521-0","article-title":"Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients","volume":"17","author":"Leonhardt","year":"2023","journal-title":"Hepatol Int"},{"key":"2026010701050453000_12.1.e001571.12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1055\/s-2006-925241","article-title":"Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up","volume":"38","author":"Jaeger","year":"2006","journal-title":"Endoscopy"},{"key":"2026010701050453000_12.1.e001571.13","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2010.537683"},{"key":"2026010701050453000_12.1.e001571.14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/lt.24192","article-title":"Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications","volume":"21","author":"Voigtl\u00e4nder","year":"2015","journal-title":"Liver Transpl"},{"key":"2026010701050453000_12.1.e001571.15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1325733"},{"key":"2026010701050453000_12.1.e001571.16","unstructured":"Neubekanntmachung der Richtlinie gem. \u00a7 16 Abs. 1 S. 1 Nrn. 2 und 5 TPG f\u00fcr die Wartelistenf\u00fchrung und Organvermittlung zur Lebertransplantation Allgemeiner Teil Besonderer Teil. 2023."},{"key":"2026010701050453000_12.1.e001571.17","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1097\/TP.0000000000001833","article-title":"\u201cModel for Early Allograft Function\u201d Outperforms \u201cEarly Allograft Dysfunction\u201d as a Predictor of Transplant Survival","volume":"101","author":"Jochmans","year":"2017","journal-title":"Transplantation"},{"key":"2026010701050453000_12.1.e001571.18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/lt.24805","article-title":"Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions","volume":"23","author":"Umgelter","year":"2017","journal-title":"Liver Transpl"},{"key":"2026010701050453000_12.1.e001571.19","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-023-07260-w","article-title":"BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis-a study protocol for a multicenter, randomized, controlled parallel group trial","volume":"24","author":"Stahl","year":"2023","journal-title":"Trials"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2024-001571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:05:17Z","timestamp":1767776717000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2024-001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,4]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjgast-2024-001571"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2024-001571","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}